×
About 20,665 results

ALLMedicine™ Renal Transplantation Center

Research & Reviews  10,199 results

Eligibility and patient barriers to peritoneal dialysis in patients with advanced chron...
https://doi.org/10.1177/0896860821998200
Peritoneal Dialysis International : Journal of the Intern... Abdulkarim S, Shah J et. al.

Mar 5th, 2021 - The burden of chronic kidney disease (CKD) is increasing in Kenya and is a significant cause of morbidity and mortality. While definitive treatment is renal transplantation, many patients require kidney replacement therapy with haemodialysis (HD) ...

A case report of tigecycline induced acute pancreatitis in a renal transplant patient a...
https://doi.org/10.1111/tid.13593
Transplant Infectious Disease : an Official Journal of Th... Yazirli B, Kara E et. al.

Mar 3rd, 2021 - Tigecycline has been approved by the U.S. (United States) Food and Drug Administration in a variety of complicated infections due to its broad-spectrum antibiotic activity. Following phase III trials, the product label was revised and acute pancre...

Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 ge...
https://doi.org/10.1111/bcp.14806
British Journal of Clinical Pharmacology; Sallustio BC, Noll BD et. al.

Mar 1st, 2021 - Long-term use of the immunosuppressant tacrolimus is limited by nephrotoxicity. Following renal transplantation, the risk of nephrotoxicity may be determined more by allograft than by blood tacrolimus concentrations, and thus may be affected by do...

Characterization of follicular T helper cells and donor-specific T helper cells in rena...
https://doi.org/10.1016/j.clim.2021.108698
Clinical Immunology (Orlando, Fla.); Subburayalu J, Dolff S et. al.

Feb 27th, 2021 - T follicular helper (TFH) cells are a heterogeneous subset of immunocompetent T helper (TH) cells capable of augmenting B cell responses in lymphoid tissues. In transplantation, exposure to allogeneic tissue activates TFH cells increasing the risk...

Pharmacodynamic Drug-Drug Interaction on Human Peripheral Blood Mononuclear Cells Betwe...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924008
Annals of Transplantation; Okihara M, Takeuchi H et. al.

Feb 26th, 2021 - BACKGROUND Everolimus (EVL) plus tacrolimus (TAC) therapy is effective and safe in renal transplantation. However, the pharmacokinetic and pharmacodynamic information for EVL combined with TAC is limited. We investigated the pharmacodynamic drug-d...

see more →

Guidelines  13 results

Clinical practice recommendations for growth hormone treatment in children with chronic...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136166
Nature Reviews. Nephrology; Drube J, Wan M et. al.

Jun 14th, 2019 - Achieving normal growth is one of the most challenging problems in the management of children with chronic kidney disease (CKD). Treatment with recombinant human growth hormone (GH) promotes longitudinal growth and likely enables children with CKD...

European Association of Urology Guidelines on Renal Transplantation: Update 2018.
https://doi.org/10.1016/j.euf.2018.07.014
European Urology Focus; Rodríguez Faba O, Boissier R et. al.

Jul 23rd, 2018 - The European Association of Urology (EAU) panel on renal transplantation (RT) has released an updated version of the RT guidelines. To present the 2018 EAU guidelines on RT. A broad and comprehensive scoping exercise was performed, encompassing al...

ACR Appropriateness Criteria® Renal Transplant Dysfunction.
https://doi.org/10.1016/j.jacr.2017.02.034
Journal of the American College of Radiology : JACR; , Taffel MT et. al.

May 5th, 2017 - Renal transplantation is the treatment of choice in patients with end-stage renal disease because the 5-year survival rates range from 72% to 99%. Although graft survival has improved secondary to the introduction of newer immunosuppression drugs ...

ACR Appropriateness Criteria Renal Transplant Dysfunction
https://www.jacr.org/article/S1546-1440(17)30217-X/fulltext
Taffel, M.

Apr 30th, 2017 - Renal transplantation is the treatment of choice in patients with end-stage renal disease because the 5-year survival rates range from 72% to 99%. Although graft survival has improved secondary to the introduction of newer immunosuppression drugs.

Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infecte...
https://academic.oup.com/cid/article/59/9/e96/422813
Gregory M. Lucas

Sep 16th, 2014 - Chronic kidney disease (CKD) is defined as abnormalities of kidney structure or function, present for >3 months, with implications for health [1]. CKD is common in human immunodeficiency virus (HIV)–infected persons, has many potential underlying.

see more →

Drugs  15 results see all →

Clinicaltrials.gov  10,317 results

Eligibility and patient barriers to peritoneal dialysis in patients with advanced chron...
https://doi.org/10.1177/0896860821998200
Peritoneal Dialysis International : Journal of the Intern... Abdulkarim S, Shah J et. al.

Mar 5th, 2021 - The burden of chronic kidney disease (CKD) is increasing in Kenya and is a significant cause of morbidity and mortality. While definitive treatment is renal transplantation, many patients require kidney replacement therapy with haemodialysis (HD) ...

A case report of tigecycline induced acute pancreatitis in a renal transplant patient a...
https://doi.org/10.1111/tid.13593
Transplant Infectious Disease : an Official Journal of Th... Yazirli B, Kara E et. al.

Mar 3rd, 2021 - Tigecycline has been approved by the U.S. (United States) Food and Drug Administration in a variety of complicated infections due to its broad-spectrum antibiotic activity. Following phase III trials, the product label was revised and acute pancre...

Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 ge...
https://doi.org/10.1111/bcp.14806
British Journal of Clinical Pharmacology; Sallustio BC, Noll BD et. al.

Mar 1st, 2021 - Long-term use of the immunosuppressant tacrolimus is limited by nephrotoxicity. Following renal transplantation, the risk of nephrotoxicity may be determined more by allograft than by blood tacrolimus concentrations, and thus may be affected by do...

Characterization of follicular T helper cells and donor-specific T helper cells in rena...
https://doi.org/10.1016/j.clim.2021.108698
Clinical Immunology (Orlando, Fla.); Subburayalu J, Dolff S et. al.

Feb 27th, 2021 - T follicular helper (TFH) cells are a heterogeneous subset of immunocompetent T helper (TH) cells capable of augmenting B cell responses in lymphoid tissues. In transplantation, exposure to allogeneic tissue activates TFH cells increasing the risk...

Pharmacodynamic Drug-Drug Interaction on Human Peripheral Blood Mononuclear Cells Betwe...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924008
Annals of Transplantation; Okihara M, Takeuchi H et. al.

Feb 26th, 2021 - BACKGROUND Everolimus (EVL) plus tacrolimus (TAC) therapy is effective and safe in renal transplantation. However, the pharmacokinetic and pharmacodynamic information for EVL combined with TAC is limited. We investigated the pharmacodynamic drug-d...

see more →

News  121 results

Caffeine Linked to Lower Mortality in CKD
https://www.staging.medscape.com/viewarticle/902567

Sep 25th, 2018 - A large observational study found a significant inverse relationship between consuming caffeine and all-cause mortality among US patients with chronic kidney disease (CKD). The research was published online September 12 in Nephrology Dialysis Tran...

Caffeine Linked to Lower Mortality in CKD
https://www.medscape.com/viewarticle/902567

Sep 25th, 2018 - A large observational study found a significant inverse relationship between consuming caffeine and all-cause mortality among US patients with chronic kidney disease (CKD). The research was published online September 12 in Nephrology Dialysis Tran...

New Clinical Practice Guidelines, August 2018 Edition
https://www.medscape.com/viewarticle/900291_15

Aug 8th, 2018 - Surgery / Anesthesiology Ketamine Infusions for Chronic Pain Renal Transplantation Vascular Surgery Arterial Procedures

New Clinical Practice Guidelines, August 2018 Edition
https://www.medscape.com/viewarticle/900291_17

Aug 8th, 2018 - Renal Transplantation European Association of Urology (7/19/2018) Check the intima of the donor and recipient arteries prior to commencing the arterial anastomosis to ensure that there is no intimal rupture/flap. If the latter is found, it must be...

In Lupus, Time on Dialysis Matters
https://www.medpagetoday.com/rheumatology/lupus/72958

May 18th, 2018 - Patients with lupus nephritis had a significantly higher risk of mortality if they spent lengthy periods of time on dialysis before undergoing renal transplantation, a retrospective review of a long-term observational registry found. Among 40 pati...

see more →